GlaxoSmithKline CEO Calls For Patent Pool
Andrew Witty, CEO of pharmaceutical company GlaxoSmithKline, said in a speech Friday at Harvard Medical School that GSK will contribute to a patent pool intended to increase innovation on medicines for neglected diseases. A Reuters story on the event is…

The Intellectual Property Watch Monthly Edition features top news on international IP policymaking, the latest on who is coming and going in the international IP community, news briefs and more. The February edition is now available for subscribers.